A Single-blinded Randomised Trial Evaluating the Efficacy of Chitosan-dextran (Chitodex) Gel Versus Gelfoam Sponge Instillation Within the Middle Ear and External Auditory Canal During Tympanoplasty Surgery

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The general purpose of this study is to compare Chitosan-dextran (Chitodex) gel versus current standard of care, Gelfoam, as a middle ear (ME) and external auditory canal (EAC) packing agent as part of tympanoplasty, ossiculoplasty and mastoidectomy procedures.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Individuals who have otoscopic evidence of tympanic membrane perforation that is also confirmed by tympanometry (Defined as a Type B tympanogram, with elevated EAC volume) AND

‣ The TM perforation is associated with at least 15dB of conductive hearing loss on the affected side AND

⁃ Are indicated to undergo closure of the perforation via tympanoplasty surgery

• OR Individuals who are indicated for ossiculoplasty due to ossicular chain disruption and its sequelae

• OR Individuals who are indicated for mastoidectomy for COM or its sequelae eg cholesteatoma

• Demonstrate healthy, dry middle ear mucosal cavities at time of surgery AND

• Are 18 years of age or over AND

• Are able to give written informed consent AND

• Are committed to returning for post-operative assessments at 2 and 6 weeks post-op, 3-, and 6- months post-op

Locations
Other Locations
Australia
The Queen Elizabeth Hospital
RECRUITING
Adelaide
The Memorial Hospital
RECRUITING
North Adelaide
Contact Information
Primary
Prof Peter-John Wormald, MD,
pjwormald@gmail.com
+61 8 82227158
Backup
Emma Barry, BSc (Hons)
emma.barry@adelaide.edu.au
+61 8 82227158
Time Frame
Start Date: 2021-11-20
Estimated Completion Date: 2025-05-13
Participants
Target number of participants: 44
Treatments
Active_comparator: Gelfoam Arm
The current standard of care in middle ear packing material has been Gelfoam, Gelfoam is an absorbable gelatin sponge manufactured from denatured porcine skin. Generally, Gelfoam resides within the middle ear for 2 to 9 weeks prior to being degraded via phagocytosis.~A single Gelfoam sponge is divided into small pieces and used within the ear. One piece of Gelfoam can typically be cut into over 200 smaller pieces. The surgeon uses approximately 10 to 20 of these smaller pieces per surgery. Approx a third of the product is applied into the middle ear, as a support material for the graft. After graft suturing is complete, the remaining two thirds are applied into the external ear canal as a packing agent.~The surgeon administers the foam during the surgery as they would with the standard TMP repair surgery. The product comes in a sterile package to be opened and cut up by Scrub Nurse.
Experimental: Chitodex Arm
Chitosan-dextran gel is packaged within a syringe and has a cannula attached, much like the Gelfoam syringe system. Approx 3-5mL of product is applied during the surgery. Approx 2mL into the middle ear, as a support material for the graft. After graft suturing is complete, another 3mL (approx) is applied into the external ear canal as a packing agent. This is the same procedure as Gelfoam is currently used for this purpose.~The surgeon will administer the gel during the surgery as they would with the standard of care Gelfoam. The product comes in a sterile kit to be opened by Scrub Nurse.
Related Therapeutic Areas
Sponsors
Collaborators: University of Adelaide
Leads: Central Adelaide Local Health Network Incorporated

This content was sourced from clinicaltrials.gov